Experts discuss how endotyping and biomarkers can help to guide treatment selection in severe type 2 asthma - touchIMMUNOLOGY
touchPANEL DISCUSSION for touchIMMUNOLOGY
Listen to leading experts discuss the serious consequences of severe type 2 asthma, how endotyping and biomarkers can help guide treatment selection in such patients, and how recent data and clinical guidelines can inform the long-term management of patients with severe type 2 asthma.
The experts
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent educational grant from Regeneron Pharmaceuticals, Inc. and Sanofi Genzyme. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchimmunologyime.org/endotypes-for-treatment-selection-in-severe-T2-asthma/
Create your
podcast in
minutes
It is Free